GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Opsens Inc (TSX:OPS) » Definitions » Debt-to-Asset

Opsens (TSX:OPS) Debt-to-Asset : 0.18 (As of Aug. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Opsens Debt-to-Asset?

Opsens's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2023 was C$0.99 Mil. Opsens's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2023 was C$8.22 Mil. Opsens's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Aug. 2023 was C$50.83 Mil. Opsens's debt to asset for the quarter that ended in Aug. 2023 was 0.18.


Opsens Debt-to-Asset Historical Data

The historical data trend for Opsens's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Opsens Debt-to-Asset Chart

Opsens Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 0.40 0.21 0.14 0.18

Opsens Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.21 0.18 0.19 0.18

Competitive Comparison of Opsens's Debt-to-Asset

For the Medical Instruments & Supplies subindustry, Opsens's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Opsens's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Opsens's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Opsens's Debt-to-Asset falls into.



Opsens Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Opsens's Debt-to-Asset for the fiscal year that ended in Aug. 2023 is calculated as

Opsens's Debt-to-Asset for the quarter that ended in Aug. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Opsens  (TSX:OPS) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Opsens Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Opsens's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Opsens (TSX:OPS) Business Description

Traded in Other Exchanges
N/A
Address
750, Boulevard du Parc-Technologique, Quebec, QC, CAN, G1P 4S3
OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. It operates in two segments that are Medical and Industrial. In Medical segment it supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices. Industrial segment includes developing, manufacturing and installing fibre optic sensing solutions for industrial applications. Majority of its revenue is derived from Medical segment.
Executives
Alan Milinazzo Director
Robin Villeneuve Senior Officer
Fiera Capital Corporation (formerly Fiera Sceptre Inc.) 10% Security Holder

Opsens (TSX:OPS) Headlines

No Headlines